The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
about
Pegylated interferon de novo-induce autoimmune haemolytic anaemia in chronic hepatitis C patient.Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysisInterferon-alpha induced and ribavirin induced thyroid dysfunction in patients with chronic hepatitis CThyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10Association of interferon-alpha and ribavirin-induced thyroid dysfunction with severity of disease and response to treatment in pakistani asian patients of chronic hepatitis C.Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis CThyroid dysfunction in chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors.Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C.The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.Hepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication
P2860
Q33161405-121581AE-CE51-4C72-9BAB-C34B048929D7Q34577136-985C5EA0-B6D7-46C2-BEED-10959C8EDF87Q35724605-28C58CC3-9294-4F4F-85FE-F0D60F75F908Q36037935-34D4F0BF-A151-4162-AADA-39DB4511A965Q36224788-72B4F9D3-06FA-4648-A1B5-10FDAE79C431Q36272069-1924EC27-C0A8-4675-AF6A-85B4E23EB81BQ36329350-30B4B7E8-D6A3-4C6B-9168-1324559A3A07Q43030689-0F8C24C1-A41A-415F-89A7-AA5C4EE4CB2FQ43034455-3686C8FC-DD7F-4FE0-9112-5C8196431661Q43520862-AF55685D-4F23-4DF7-BDD3-64C9FA561CD7Q50553281-E95937BE-A7AB-4D21-B2A1-4C1496EC7BCAQ57982384-381BAB4E-F4A5-4294-BE78-119ACDAD8D2D
P2860
The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
The role of thyroid autoantibo ...... ribavirin combination therapy.
@en
The role of thyroid autoantibo ...... ribavirin combination therapy.
@nl
type
label
The role of thyroid autoantibo ...... ribavirin combination therapy.
@en
The role of thyroid autoantibo ...... ribavirin combination therapy.
@nl
prefLabel
The role of thyroid autoantibo ...... ribavirin combination therapy.
@en
The role of thyroid autoantibo ...... ribavirin combination therapy.
@nl
P2093
P2860
P1476
The role of thyroid autoantibo ...... ribavirin combination therapy.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2893.2005.00705.X
P50
P577
2006-06-01T00:00:00Z